Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

Authors:
  • FPfor the Management of Stage III NSCLC Guideline Expert Panel
    for the Management of Stage III NSCLC Guideline Expert Panel
  • MAMara B. Antonoff
    Mara B. Antonoff
  • DADouglas A. Arenberg
    Douglas A. Arenberg
  • JBJeffrey Bradley
    Jeffrey Bradley
  • EDElizabeth David
    Elizabeth David
  • FDFrank Detterbeck
    Frank Detterbeck
  • MFMartin Früh
    Martin Früh
  • MGMatthew A. Gubens
    Matthew A. Gubens
  • AMAmy C. Moore
    Amy C. Moore

Abstract
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. See the Appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 , online only).